It has been shown how the immune system is affected differently depending on the bacterial composition of each animal. The results of this study, which also involved researchers from the Universitat M...
Read morePHEMS project will advance data-driven research and innovation activities in pediatrics and the use of privacy-preserving datasets in Europe. The project’s aim is to overcome important barriers that...
Read moreAgomab Therapeutics NV ('Agomab') today announced the closing of a $100 million Series C round of financing to support the Phase 2a clinical trial evaluating Agomab's lead drug candidate, AGMB-129, a ...
Read moreIt has been made a revealing finding in the fight against alcohol-related liver disease, shedding light on the role of miR-873-5p as a possible key regulator in protecting the liver from alcohol damag...
Read moreAM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacemen...
Read moreEl biomaterial desarrollado por los investigadores consiste en una membrana del cascarón de un huevo de gallina recubierta con nanocristales de apatito capaz de estimular las células formadoras del ...
Read moreCPC-containing mouthwashes could be a safe, easy and cost-effective measure to limit infectivity and the ability to transmit viruses
Read moreIt has been combined STED microscopy, a technology that allows super-resolution visualization, and a new antibody recently created to observe the amyloidogenic aggregates characteristic of Alzheimer's...
Read moreSe observó un aumento significativo de resistencia a eritromicina, que se correlacionó con un aumento en el consumo de este tipo de antibióticos. La investigación apoya la hipótesis que señala a...
Read moreInvestigadores del Programa de Tumores Sólidos del Cima Universidad de Navarra han identificado una nueva combinación de fármacos que mejora el tratamiento de modelos experimentales de cáncer de p...
Read moreVIGex es una firma de expresión génica que clasifica los tumores sólidos en tres categorías según el estado de activación de los genes de respuesta inmunológica adaptativa: Caliente, Intermedio...
Read moreLa herramienta AlphaMissense es capaz de predecir el efecto de cualquier sustitución de aminoácidos en el proteoma humano.
Read more